A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium–Glucose Cotransporter 2 Inhibitor-Reference-Cited by-同舟云学术

A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium–Glucose Cotransporter 2 Inhibitor

Published:2020-04-01 Issue:2 Volume:38 Page:204-207
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Garay Paola Sanchez¹,Zuniga Gabriela²^ORCID,Lichtenberg Robert¹

Affiliation:

1. Department of Internal Medicine, Loyola Medicine – MacNeal Hospital, Berwyn, IL

2. Department of Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/38/2/204/501179/diaclincd190055.pdf

Reference17 articles.

1. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium–glucose cotransporter 2 inhibition;Peters;Diabetes Care,2015

2. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors;Ogawa;J Diabetes Investig,2016

3. Sodium glucose co-transporter-2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology;Kalra;Diabetes Ther,2014

4. Euglycemic diabetic ketoacidosis with prolonged glucosuria associated with the sodium-glucose cotransporter-2 canagliflozin;Kelmenson;J Investig Med High Impact Case Rep,2017

5. Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma;Rawla;Endocrinol Diabetes Metab Case Rep,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of ketogenic therapy in patients with obesity and diabetes: a narrative review;Exploration of Foods and Foodomics;2024-07-17

2. Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links;Clinica Chimica Acta;2023-01

3. Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians?;Korean Journal of Family Medicine;2022-11-20

4. Empagliflozin;Reactions Weekly;2022-11-12

5. Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor;Case Reports in Endocrinology;2022-03-02